Further understanding of the regulation of the TLS system, including Y-family DNA polymerases and other polymerases such as Polζ, might open up a novel avenue for future cancer chemotherapy based on genomic information and the transcriptome of cancer cells from each patient. Here, REV3L is linked to cancer.